Valuation: Center Laboratories, Inc.

Market Cap 29.38B 914M 800M 737M 683M 1.3B 86.75B 1.32B 8.84B 3.44B 42.81B 3.43B 3.36B 148B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 33.42B 1.04B 910M 839M 777M 1.48B 98.69B 1.5B 10.06B 3.91B 48.7B 3.9B 3.82B 168B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day-0.75%
1 week+3.81%
Current month+3.54%
1 month+1.80%
3 months-5.28%
6 months-1.62%
Current year-5.05%
1 week 37.9
Extreme 37.9
40.55
1 month 36.8
Extreme 36.8
40.55
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 03/08/1998
Director of Finance/CFO - 08/12/2022
Chief Tech/Sci/R&D Officer - 01/07/1983
Director TitleAgeSince
Chairman - 30/11/2022
Director/Board Member 61 14/06/2010
Director/Board Member - 14/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%+3.81%+12.63%-20.11% 918M
+0.30%+3.19%+58.14%+171.37% 1,102B
-0.07%+4.88%+70.98%+66.99% 643B
-0.17%+0.78%+33.32%+88.13% 450B
+1.58%-2.07%+27.62%+22.57% 336B
-0.42%-0.32%+29.27%+48.60% 288B
-1.11%+2.78%-26.71%-39.79% 222B
+0.53%+1.44%+23.41%+63.10% 199B
-0.50%+7.26%+21.66%+78.52% 169B
+1.02%+1.49%-5.41%-32.08% 137B
Average +0.03%+2.17%+24.49%+44.73% 354.6B
Weighted average by Cap. +0.11%+1.86%+40.63%+86.22%

Financials

2024 2025
Net sales 1.62B 50.34M 44.05M 40.6M 37.63M 71.44M 4.78B 72.59M 487M 189M 2.36B 189M 185M 8.15B 1.52B 47.18M 41.29M 38.05M 35.27M 66.95M 4.48B 68.03M 456M 177M 2.21B 177M 173M 7.64B
Net income -1.1B -34.34M -30.05M -27.7M -25.67M -48.73M -3.26B -49.52M -332M -129M -1.61B -129M -126M -5.56B 9.32B 290M 254M 234M 217M 412M 27.53B 418M 2.81B 1.09B 13.59B 1.09B 1.07B 46.96B
Net Debt 4.48B 139M 122M 112M 104M 198M 13.23B 201M 1.35B 524M 6.53B 523M 512M 22.57B 4.04B 126M 110M 101M 94M 178M 11.93B 181M 1.22B 473M 5.89B 472M 462M 20.36B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
08/07/26 NT$39.35 -0.38% 2,447,035
07/07/26 NT$39.50 -0.75% 2,544,596
06/07/26 NT$39.80 +0.38% 4,071,591
03/07/26 NT$39.65 +3.26% 8,219,167
02/07/26 NT$38.40 +0.79% 3,044,141
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. 4123 Stock